Further mechanism study found that HIF‐1α mediates the inhibition of miR‐338‐5p, interferes with the regulation of miR‐338‐5p on the downstream direct target IL‐6, mediates the activation of STAT3/BCL2 signalling pathway and enhances CRC resistance to oxaliplatin.36 This evidence concerns the gene IL6 and colorectal carcinoma.